Aytu BioPharma (NASDAQ:AYTU) Announces Earnings Results

Aytu BioPharma (NASDAQ:AYTU) issued its quarterly earnings results on Wednesday. The company reported ($0.28) EPS for the quarter, Zacks reports. Aytu BioPharma had a negative return on equity of 21.89% and a negative net margin of 8.28%.

Aytu BioPharma Stock Down 2.1 %

AYTU stock opened at $1.39 on Thursday. Aytu BioPharma has a 12 month low of $1.30 and a 12 month high of $3.45. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.99 and a quick ratio of 0.80. The firm has a 50 day simple moving average of $1.62 and a 200 day simple moving average of $2.01.

About Aytu BioPharma

Aytu Biopharma, Inc is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers.